Question 1

What is Biktarvy?

Accepted Answer

Biktarvy is a combination medication that contains bictegravir , emtricitabine , and tenofovir alafenamide . It is classified as an antiretroviral drug and is primarily used in the management of human immunodeficiency virus (HIV) infection.

Biktarvy works by inhibiting the replication of the virus within the body, helping to control the progression of HIV. It is commonly associated with the long-term management of HIV in adults and adolescents.

Question 2

What is Biktarvy used for?

Accepted Answer

Biktarvy is used to treat HIV-1 infection .

Question 3

How does Biktarvy work?

Accepted Answer

How Biktarvy Works

Biktarvy contains three active ingredients: bictegravir, emtricitabine, and tenofovir alafenamide. These drugs belong to two different classes of antiretroviral medications that target the human immunodeficiency virus (HIV) at different stages of its life cycle.

Blocking Viral Replication

The components of Biktarvy work by interfering with specific enzymes that the virus uses to make copies of itself:

Bictegravir: This is an integrase strand transfer inhibitor (INSTI). It blocks an enzyme called integrase, which HIV uses to insert its own genetic material into the DNA of healthy human cells.

Emtricitabine and Tenofovir Alafenamide: These are nucleoside reverse transcriptase inhibitors (NRTIs). They block an enzyme called reverse transcriptase, which the virus needs to convert its genetic material into a form that can be integrated into human cells.

Effects on the Body

By preventing the virus from multiplying, Biktarvy helps to:

Reduce the amount of HIV in the blood, often referred to as the viral load.

Increase the number of CD4 cells (T-cells), which are white blood cells that help the immune system fight infections.

While Biktarvy helps control the infection and can make the viral load undetectable, it is not a cure for HIV or AIDS. It must be taken consistently to keep the virus from replicating and to prevent the immune system from becoming weaker.

Question 4

What are the active ingredients in Biktarvy?

Accepted Answer

The active ingredients in Biktarvy are:

Tenofovir alafenamide

Bictegravir

Emtricitabine

Question 5

What are the side effects of Biktarvy?

Accepted Answer

Common side effects of Biktarvy may include:

diarrhea

nausea

headache

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Biktarvy?

Accepted Answer

Biktarvy belongs to the antiretroviral combination drug class .

Question 7

What is the dosage of Biktarvy and how do I take it?

Accepted Answer

How to Take Biktarvy

Biktarvy is a tablet that should be taken exactly as prescribed by a healthcare provider. It is typically taken once a day at approximately the same time each day.

Administration: Swallow the tablet whole. Do not chew, crush, or split the tablet.

Food: You may take this medication with or without food.

Missed Doses

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

Timing with Other Medications

Certain supplements and medications can interfere with how Biktarvy is absorbed. This includes antacids containing magnesium or aluminum, as well as supplements containing iron or calcium. Your doctor may advise you to take Biktarvy at a different time than these products, such as taking them together with food or separating the doses by several hours.

Question 8

Is Biktarvy safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data regarding the safety of Biktarvy during pregnancy is limited. While studies in animals have not shown a clear risk of harm to the fetus, there is not enough information from human studies to determine if the medication is safe for use during pregnancy. Healthcare providers may encourage pregnant individuals taking Biktarvy to enroll in the Antiretroviral Pregnancy Registry to help monitor the health of both the parent and the baby.

It is important to maintain effective HIV treatment during pregnancy to protect the health of the parent and to lower the risk of passing the virus to the child. Decisions about using Biktarvy during pregnancy should be made in consultation with a healthcare professional.

Breastfeeding

The Centers for Disease Control and Prevention (CDC) and other health organizations recommend that people with HIV-1 do not breastfeed their infants. This recommendation is intended to prevent the transmission of HIV to the baby through breast milk. Furthermore, it is known that some ingredients in Biktarvy can pass into breast milk, and the potential for serious adverse reactions in a nursing infant is unknown.

Question 9

What forms and strengths does Biktarvy come in?

Accepted Answer

Dosage Forms

Biktarvy is supplied as a film-coated tablet for oral administration. It is a fixed-dose combination medication that contains multiple active ingredients in a single pill.

The tablets are produced in different sizes to accommodate use in adults and pediatric patients based on body weight. The tablets are typically capsule-shaped or round, depending on the specific formulation prescribed by a healthcare provider.

Question 10

What is the FDA approval status of Biktarvy?

Accepted Answer

FDA Approval and Indications

Biktarvy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV-1 infection. It is a complete regimen, meaning it is not intended to be taken with other antiretroviral drugs. The medication is indicated for adults and pediatric patients weighing at least 14 kilograms. It may be used in patients who have not previously received HIV treatment or as a replacement for a current stable regimen in patients who are virologically suppressed and have no history of treatment failure.

Boxed Warning

The FDA requires a boxed warning for Biktarvy because it contains emtricitabine and tenofovir alafenamide, which can cause a severe acute exacerbation of hepatitis B (HBV) in patients co-infected with HIV-1 and HBV who stop taking the medication. Healthcare providers are advised to test all patients for HBV infection before starting Biktarvy. If the medication is discontinued, liver function must be monitored closely through both clinical and laboratory follow-up for at least several months.

Other Regulatory Information

Biktarvy is a prescription-only medication. It is not indicated for the treatment of chronic HBV infection. While it is used to manage HIV-1, it is not a cure for HIV or AIDS.

Question 11

What should I know about Biktarvy and cost?

Accepted Answer

Insurance Coverage

The out-of-pocket cost for Biktarvy is primarily determined by your health insurance plan. Most private insurance, Medicare, and Medicaid plans cover Biktarvy, but the specific copayment or coinsurance amount varies by plan. Since Biktarvy is a brand-name medication and does not currently have a generic version, costs may be higher than for some other treatments.

Savings and Support Options

Several programs may be available to help manage the cost of Biktarvy:

Manufacturer Copay Cards: Eligible patients with commercial insurance may use copay savings cards to reduce their monthly out-of-pocket costs.

Patient Assistance Programs: For those who are uninsured or have limited insurance coverage, the manufacturer may offer programs that provide the medication at no cost or a significantly reduced price based on income eligibility.

State Assistance: Programs like the AIDS Drug Assistance Program (ADAP) can help eligible individuals obtain HIV medications.

Patients should consult their pharmacist or insurance provider for specific pricing information and to explore available financial support.

Biktarvy

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?